Spoken Alpha
IM Cannabis Corp.
IM Cannabis Corp is a Healthcare company operating in Drug Manufacturers - Specialty & Generic with a $1.2M market cap.
Most recent earnings call: Q1 FY25 on May 15, 2025.
14 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-08-30.
Transcripts
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Peers
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for IMCC.
$ curl https://api.spokenalpha.com/v1/companies/IMCCFAQ
Spoken Alpha indexes IMCC's earnings call transcripts at https://spokenalpha.com/companies/IMCC. Each call links to attributed speakers and parsed analyst Q&A. IM Cannabis Corp.'s own investor relations page is at https://investors.imcannabis.com/.
IM Cannabis Corp. (IMCC) held its most recent earnings call on 2025-05-15, covering fiscal Q1 2025.
IM Cannabis Corp. (IMCC) operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).